Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300955892> ?p ?o ?g. }
- W4300955892 endingPage "2174" @default.
- W4300955892 startingPage "2165" @default.
- W4300955892 abstract "BACKGROUND Surgery is the standard treatment for patients with resectable esophageal carcinoma, but the long term prognosis of these patients is unsatisfactory. Some randomized trials of preoperative chemotherapy suggest that the prognosis of patients who respond may be improved. METHODS This randomized, controlled trial compared patients with clinically resectable esophageal epidermoid carcinoma who underwent surgery alone (Arm A) with those who received preoperative chemotherapy (Arm B). Overall survival and the prognostic impact of major response to chemotherapy were analyzed. Forty-eight patients were enrolled in each arm. Chemotherapy consisted of two or three cycles of cisplatin (100 mg/m2 on Day 1) and 5- fluorouracil (1000 mg/m2 per day continuous infusion on Days 1–5). In both study arms, transthoracic esophagectomy plus two-field lymphadenectomy was performed. The two groups were comparable in terms of patient characteristics. RESULTS Forty-seven patients were evaluable in each arm. The curative resection rate was 74.4% (35 of 47 patients) in Arm A and 78.7% (37 of 47 patients) in Arm B. Treatment-related mortality was 4.2% in both arms. The response rate to preoperative chemotherapy was 40% (19 of 47 patients), including 6 patients (12.8%) who achieved a pathologic complete responses. Overall survival was not improved significantly. The 19 patients in Arm B who responded to chemotherapy and underwent curative resection had significantly better 3-year and 5-year survival rates (74% and 60%, respectively) compared with both nonresponders (24% and 12%, respectively; P = 0.0002) and patients in Arm A who underwent complete resection (46% and 26%, respectively; P = 0.01): Patients who achieved a pathologic complete response (P = 0.01), but not those who achieved a partial response (P = 0.2), had significantly improved survival. CONCLUSIONS Patients with resectable esophageal carcinoma who underwent preoperative chemotherapy and obtained a pathologic complete response had a significantly improved long term survival. Major efforts should be undertaken to identify patients before neoadjuvant treatments who are likely to respond. Cancer 2001;91:2165–74. © 2001 American Cancer Society." @default.
- W4300955892 created "2022-10-04" @default.
- W4300955892 creator A5006953770 @default.
- W4300955892 creator A5009875698 @default.
- W4300955892 creator A5012466441 @default.
- W4300955892 creator A5021943417 @default.
- W4300955892 creator A5023891520 @default.
- W4300955892 creator A5031591368 @default.
- W4300955892 creator A5036178622 @default.
- W4300955892 creator A5039389370 @default.
- W4300955892 creator A5090223971 @default.
- W4300955892 date "2001-01-01" @default.
- W4300955892 modified "2023-10-06" @default.
- W4300955892 title "Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma" @default.
- W4300955892 cites W1504555808 @default.
- W4300955892 cites W1536690700 @default.
- W4300955892 cites W1901180305 @default.
- W4300955892 cites W1921758104 @default.
- W4300955892 cites W1991374147 @default.
- W4300955892 cites W2006329075 @default.
- W4300955892 cites W2007389503 @default.
- W4300955892 cites W2012004545 @default.
- W4300955892 cites W2012291466 @default.
- W4300955892 cites W2022687894 @default.
- W4300955892 cites W2029081428 @default.
- W4300955892 cites W2038180810 @default.
- W4300955892 cites W2063756893 @default.
- W4300955892 cites W2075362684 @default.
- W4300955892 cites W2082670172 @default.
- W4300955892 cites W2089001382 @default.
- W4300955892 cites W2093208418 @default.
- W4300955892 cites W2093658700 @default.
- W4300955892 cites W2103170361 @default.
- W4300955892 cites W2111761059 @default.
- W4300955892 cites W2115664660 @default.
- W4300955892 cites W2120014319 @default.
- W4300955892 cites W2148658649 @default.
- W4300955892 cites W2313229551 @default.
- W4300955892 cites W2333224485 @default.
- W4300955892 cites W2338880854 @default.
- W4300955892 cites W2347198999 @default.
- W4300955892 cites W4239011888 @default.
- W4300955892 doi "https://doi.org/10.1002/1097-0142(20010601)91:11<2165::aid-cncr1245>3.0.co;2-h" @default.
- W4300955892 hasPublicationYear "2001" @default.
- W4300955892 type Work @default.
- W4300955892 citedByCount "297" @default.
- W4300955892 countsByYear W43009558922012 @default.
- W4300955892 countsByYear W43009558922013 @default.
- W4300955892 countsByYear W43009558922014 @default.
- W4300955892 countsByYear W43009558922015 @default.
- W4300955892 countsByYear W43009558922016 @default.
- W4300955892 countsByYear W43009558922017 @default.
- W4300955892 countsByYear W43009558922018 @default.
- W4300955892 countsByYear W43009558922019 @default.
- W4300955892 countsByYear W43009558922020 @default.
- W4300955892 countsByYear W43009558922021 @default.
- W4300955892 countsByYear W43009558922022 @default.
- W4300955892 countsByYear W43009558922023 @default.
- W4300955892 crossrefType "journal-article" @default.
- W4300955892 hasAuthorship W4300955892A5006953770 @default.
- W4300955892 hasAuthorship W4300955892A5009875698 @default.
- W4300955892 hasAuthorship W4300955892A5012466441 @default.
- W4300955892 hasAuthorship W4300955892A5021943417 @default.
- W4300955892 hasAuthorship W4300955892A5023891520 @default.
- W4300955892 hasAuthorship W4300955892A5031591368 @default.
- W4300955892 hasAuthorship W4300955892A5036178622 @default.
- W4300955892 hasAuthorship W4300955892A5039389370 @default.
- W4300955892 hasAuthorship W4300955892A5090223971 @default.
- W4300955892 hasBestOaLocation W43009558921 @default.
- W4300955892 hasConcept C121608353 @default.
- W4300955892 hasConcept C126322002 @default.
- W4300955892 hasConcept C141071460 @default.
- W4300955892 hasConcept C168563851 @default.
- W4300955892 hasConcept C2776283816 @default.
- W4300955892 hasConcept C2776694085 @default.
- W4300955892 hasConcept C2777297899 @default.
- W4300955892 hasConcept C2777546739 @default.
- W4300955892 hasConcept C2777819096 @default.
- W4300955892 hasConcept C2779742542 @default.
- W4300955892 hasConcept C2780323790 @default.
- W4300955892 hasConcept C2780456651 @default.
- W4300955892 hasConcept C2780824555 @default.
- W4300955892 hasConcept C71924100 @default.
- W4300955892 hasConcept C90924648 @default.
- W4300955892 hasConceptScore W4300955892C121608353 @default.
- W4300955892 hasConceptScore W4300955892C126322002 @default.
- W4300955892 hasConceptScore W4300955892C141071460 @default.
- W4300955892 hasConceptScore W4300955892C168563851 @default.
- W4300955892 hasConceptScore W4300955892C2776283816 @default.
- W4300955892 hasConceptScore W4300955892C2776694085 @default.
- W4300955892 hasConceptScore W4300955892C2777297899 @default.
- W4300955892 hasConceptScore W4300955892C2777546739 @default.
- W4300955892 hasConceptScore W4300955892C2777819096 @default.
- W4300955892 hasConceptScore W4300955892C2779742542 @default.
- W4300955892 hasConceptScore W4300955892C2780323790 @default.
- W4300955892 hasConceptScore W4300955892C2780456651 @default.
- W4300955892 hasConceptScore W4300955892C2780824555 @default.
- W4300955892 hasConceptScore W4300955892C71924100 @default.